New South Wales has become the first Australian state to make motor neurone disease (MND) a legally reportable condition, mandating that medical practitioners notify health authorities when a diagnosis is made. The change, set to take effect this week, aims to enhance understanding of the illness, improve healthcare planning, and support ongoing research.
MND is a progressive and fatal neurological disease that affects motor neurons, the nerve cells responsible for transmitting signals from the brain to muscles via the spinal cord. These affected neurons deteriorate over time, leading to loss of muscle control. Approximately eight in every 100,000 Australians are diagnosed with MND, with 90 percent of cases appearing sporadically, without clear familial or genetic causes. Currently, no cure exists.
The new reporting requirement is intended to establish a comprehensive database to better track the incidence and distribution of MND across the state. Health Minister Ryan Park emphasized the importance of this step, expressing hope that the collected data will enable researchers and clinicians to develop improved treatments, preventive measures, and potentially a cure in the future.
“We hope that by building this knowledge base, our incredible medical researchers and clinicians can do what they do best,” Park said ahead of the formal announcement.
Advocates and affected families have welcomed the change. Ron Hobden, diagnosed with MND three years ago at age 35, described the impact of the disease on his daily life. He recounted losing fundamental abilities such as walking, speaking, self-feeding, and physical contact with his family, relying instead on eye movement to communicate and tube feeding for nutrition. His wife, Annie Hobden, said the announcement brought a sense of relief to the MND community, which has long sought greater recognition and understanding of the disease.
“There’s relief in finally being able to say – we are going to start counting,” she said, highlighting the potential for new insights into patterns of diagnosis and geographical distribution.
Liam O’Meara, chief executive of MND NSW, called the introduction of mandatory reporting a “fantastic step forward” and a move closer to identifying the causes of the disease. Citing his personal experience with MND through family losses, O’Meara stressed that more complete data collection could provide better insights and urged other Australian jurisdictions to consider similar measures.
Notably, National Rugby League player Jai Arrow marked his 100th and final game for the South Sydney Rabbitohs last week after being diagnosed with MND. Arrow has spoken publicly about the importance of collecting detailed records of MND cases to advance research efforts.
While the Hobdens acknowledge that tracking the disease may not alter their personal prognosis, they view the initiative as a way to contribute to a broader legacy. “We may not see the cure we’re fighting for,” Annie Hobden said, “but legacy isn’t only what you leave behind – it’s what you help change while you’re here.”
The introduction of mandatory reporting for MND in New South Wales represents a significant move toward improved disease surveillance, with the potential to inform future medical breakthroughs and healthcare resource allocation.